159 related articles for article (PubMed ID: 12195937)
61. [Protective effects of WR2721 on early bone marrow hematopoietic function in mice exposed to 6.5 Gy of (60)Co γ-rays].
Deng ZL; Zhang LZ; Cong Y; Liu XL; Yu ZY; Shan YJ; Cui Y; Wang LM; Xing S; Cong YW; Luo QL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):791-6. PubMed ID: 24989296
[TBL] [Abstract][Full Text] [Related]
62. [Effects of mesenchymal stem cells on cell cycle and apoptosis of hematopoietic tissue cells in irradiated mice].
Hu KX; Zhao SF; Guo M; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1226-30. PubMed ID: 18088472
[TBL] [Abstract][Full Text] [Related]
63. Mushroom beta glucan: potential candidate for post irradiation protection.
Pillai TG; Uma Devi P
Mutat Res; 2013 Mar; 751(2):109-15. PubMed ID: 23277319
[TBL] [Abstract][Full Text] [Related]
64. [Effect of PF4 on 60Co gamma ray irradiation-induced bone marrow cell apoptosis in mice].
Lin HL; Yang L; Wang XR; Gu HT; Gao GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Sep; 23(9):813-5. PubMed ID: 17825225
[TBL] [Abstract][Full Text] [Related]
65. The effects in mice of combined treatments to X-rays and antineoplastic drugs in the Comet assay.
Dobrzyńska MM
Toxicology; 2005 Feb; 207(2):331-8. PubMed ID: 15596263
[TBL] [Abstract][Full Text] [Related]
66. The modulatory effect of aminothiols on the clastogenic activity of X-rays assayed by the vivo mouse micronucleus test.
Mazur L
Folia Biol (Krakow); 1996; 44(1-2):55-9. PubMed ID: 9008427
[TBL] [Abstract][Full Text] [Related]
67. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
[TBL] [Abstract][Full Text] [Related]
68. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
69. Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Fulda S; Fichtner I; Hero B; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):199-202. PubMed ID: 11464883
[TBL] [Abstract][Full Text] [Related]
70. Low dose radiation increased the therapeutic efficacy of cyclophosphamide on S(180) sarcoma bearing mice.
Yu HS; Xue HW; Guo CB; Song AQ; Shen FZ; Liang J; Deng C
J Radiat Res; 2007 Jul; 48(4):281-8. PubMed ID: 17548941
[TBL] [Abstract][Full Text] [Related]
71. Differential biologic effects of CPD and 6-4PP UV-induced DNA damage on the induction of apoptosis and cell-cycle arrest.
Lo HL; Nakajima S; Ma L; Walter B; Yasui A; Ethell DW; Owen LB
BMC Cancer; 2005 Oct; 5():135. PubMed ID: 16236176
[TBL] [Abstract][Full Text] [Related]
72. Quercetin-3-rutinoside protects against gamma radiation inflicted hematopoietic dysfunction by regulating oxidative, inflammatory, and apoptotic mediators in mouse spleen and bone marrow.
Dutta A; Dahiya A; Verma S
Free Radic Res; 2021 Mar; 55(3):230-245. PubMed ID: 34044723
[TBL] [Abstract][Full Text] [Related]
73. Amifostine ameliorates recognition memory defect in acute radiation syndrome caused by relatively low-dose of gamma radiation.
Lee HJ; Kim JS; Song MS; Seo HS; Yang M; Kim JC; Jo SK; Shin T; Moon C; Kim SH
J Vet Sci; 2010 Mar; 11(1):81-3. PubMed ID: 20195069
[TBL] [Abstract][Full Text] [Related]
74. WR-1065 and radioprotection of vascular endothelial cells. I. Cell proliferation, DNA synthesis and damage.
Rubin DB; Drab EA; Kang HJ; Baumann FE; Blazek ER
Radiat Res; 1996 Feb; 145(2):210-6. PubMed ID: 8606931
[TBL] [Abstract][Full Text] [Related]
75. The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs: its importance to solid tumour chemotherapy.
el Alaoui S; Lawry J; Griffin M
J Neurooncol; 1997 Jan; 31(1-2):195-207. PubMed ID: 9049849
[TBL] [Abstract][Full Text] [Related]
76. Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma.
Avilés A; Díaz-Maqueo JC; Talavera A; García EL; Guzmán R; Nambo MJ
Eur J Cancer; 1997 Jul; 33(8):1323-5. PubMed ID: 9301462
[TBL] [Abstract][Full Text] [Related]
77. Prevention of myelosuppression and genotoxicity induced by cisplatin in murine bone marrow cells: effect of an organovanadium compound vanadium(III)-l-cysteine.
Basu A; Ghosh P; Bhattacharjee A; Patra AR; Bhattacharya S
Mutagenesis; 2015 Jul; 30(4):509-17. PubMed ID: 25778689
[TBL] [Abstract][Full Text] [Related]
78. New protective agents for bone marrow in cancer therapy.
McCulloch W; Scheffler BJ; Schein PS
Cancer Invest; 1991; 9(3):279-87. PubMed ID: 1655173
[TBL] [Abstract][Full Text] [Related]
79. Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitro.
Fulda S; Oster W; Berthold F
Anticancer Drugs; 1997 Jan; 8(1):34-41. PubMed ID: 9147609
[TBL] [Abstract][Full Text] [Related]
80. Amifostine does not protect thyroid cancer cells in DNA damaging
Klubo-Gwiezdzinska J; Costello J; Jensen K; Patel A; Tkavc R; Van Nostrand D; Burman KD; Wartofsky L; Vasko V
Endocr Connect; 2017 Oct; 6(7):469-478. PubMed ID: 28790138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
